← All chemicals

CAS 584-84-9

Toluene-2,4-diisocyanate (TDI)

isocyanateHAPrespiratory sensitizercarcinogen

Toluene-2,4-diisocyanate is the dominant monomer used in flexible polyurethane foam production — the material in mattresses, upholstered furniture, and car seats — and is simultaneously the most important cause of occupational asthma in the global chemical industry, affecting thousands of workers annually through an immune sensitization that permanently disables them from working with isocyanates.

Where It Comes From

TDI was developed by Bayer in the 1930s and became commercially important in the post-WWII polyurethane revolution [1]. Otto Bayer's discovery that diisocyanates react with polyols to form polyurethane polymers opened the path to flexible foam, rigid insulation, coatings, and elastomers that transformed the modern world [2]. Global TDI production exceeds 2 million tonnes annually — the foam in virtually every mattress, sofa, and car seat in the world was made with TDI [1]. The industrial synthesis starts with toluenediamine (2,4-TDA) + phosgene → TDI, meaning TDI production facilities also handle the highly toxic phosgene gas [2]. TDI is highly reactive with any nucleophile, including water (liberating CO₂ during foam production), which is why freshly foam-cut surfaces and foam factories have distinctive acrid odors [1].

How You Are Exposed

Workers in flexible polyurethane foam manufacturing — mixing polyol and TDI, pouring into molds, cutting and shaping foam — have the highest inhalation exposures [1]. TDI is highly volatile (vapor pressure 1.3 mmHg at 20°C) and reaches airborne concentrations that sensitize workers, sometimes in a single severe exposure [2]. Furniture manufacturers, automotive seat assemblers, and spray foam insulation workers face secondary exposures [1]. Consumer exposure from finished polyurethane foam products is minimal — TDI reacts essentially completely during foam production, leaving no residual monomer in the product [2].

Why It Matters

TDI causes occupational asthma through two mechanisms: IgE-mediated (classical atopic sensitization) and non-IgE-mediated T-cell reactions [1]. Both require initial sensitization — either from a single high-level exposure or from repeated low-level exposures over time. Once sensitized, even nanogram quantities of TDI in air trigger an asthmatic attack [2]. Sensitization from isocyanates is permanent — affected workers must permanently avoid all isocyanate exposure, which often ends their career in foam manufacturing [1]. IARC classifies TDI as a Group 2B possible carcinogen based on lung and pancreatic tumors in animal studies [2].

Who Is at Risk

Polyurethane foam production workers, spray foam insulation applicators, and auto body painters using isocyanate-containing two-part paints are the highest-risk groups [1]. Workers who experience a single high-level TDI exposure are at greatest risk for sensitization [2]. People living near polyurethane foam manufacturing facilities may face community air exposure [1].

How to Lower Your Exposure

1. Strict engineering controls — enclosed foam pouring systems, local exhaust ventilation at cutting and trimming stations — are essential [1]. 2. Continuous TDI air monitoring with alarm thresholds below the occupational exposure limit (OSHA PEL: 0.005 ppm ceiling) [2]. 3. Any worker experiencing respiratory symptoms after TDI exposure should be evaluated immediately — early sensitization, before the first severe asthma attack, may be partially reversible [1]. 4. Spray foam applicators must use supplied-air respirators (not just OV cartridges) in confined spaces [2].

References

  1. [1]OSHA (2023). Diisocyanates in the Workplace. https://www.osha.gov/diisocyanates
  2. [2]ATSDR (2014). Toxicological Profile for Toluene Diisocyanate. https://www.atsdr.cdc.gov/toxprofiles/tp125.pdf

Recovery & Clinical Information

Body Half-Life

TDI reacts immediately upon inhalation — blood TDI half-life is effectively zero at respiratory tract surfaces [1]. Urinary toluenediamine (TDA) metabolites are excreted within 24-48 hours [2].

Testing & Biomarkers

Urine TDA (hydrolysis metabolite) by GC-MS for post-exposure monitoring [1]. Pulmonary function testing (FEV1, FEV1/FVC, methacholine challenge) for sensitization detection [2].

Interventions

Immediate removal from all isocyanate exposure upon first sign of sensitization — continued exposure after sensitization is extremely dangerous [1]. Bronchodilators and corticosteroids for asthma management; inhaled steroids for maintenance [2]. Once sensitized, no treatment reverses isocyanate sensitivity [1].

Recovery Timeline

Acute bronchospasm from TDI resolves within hours with bronchodilator treatment [1]. Isocyanate sensitization, once established, is permanent [2]. Some lung function recovery may occur over months to years after complete isocyanate exposure removal [1].

Recovery References

  1. [1]OSHA Diisocyanates. https://www.osha.gov/diisocyanates
  2. [2]ATSDR (2014). Toxicological Profile for TDI. https://www.atsdr.cdc.gov/toxprofiles/tp125.pdf

Track your exposure to Toluene-2,4-diisocyanate (TDI)

Pollution Profile maps your lifetime exposure history to EPA-tracked chemicals.

Get early access

We use cookies and analytics to understand how people use Pollution Profile and improve the experience. We never sell your data. Learn more.